Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05182164
Title Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas (PEMBROCABOSARC)
Acronym PEMBROCABOSARC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonie
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.